A monthly Internet and Hard Copy publication featuring:
breaking news and corporate changes with CEO, CFO and Analyst interviews

Cover Story

CEOCFO
Interview
Index &
Quotes

CEOCFO
Current Issue


Future
Features

Monthly
Analyst
Industry
Review

Analyst
Interviews
and Reports

Corporate
Financials

Newsflash!
 
Archived
CEOCFO
Interviews

 

About
CEOCFO
interviews.com

Contact & Ordering

 

 

Milestone Scientific Inc. – No pain but plenty of gain for The Wand®:
a break through technology for the dental arena now available in
medical markets


wpe3A.jpg (5650 bytes)

 Healthcare
Medical Equipment & Supply
AMEX: MS


Milestone Scientific Inc.

220 South Orange Avenue
Livingston, NJ 07039



wpe28.jpg (6809 bytes)

Leonard Osser
Chairman and
Chief Executive Officer

Interview conducted by:
Walter Banks, Co-Publisher

CEOCFOinterviews,com
September 2001

BIO OF CEO

Leonard A. Osser has been Chief Executive Officer and a director of the Company since July 1991, and the President and Chief Executive Officer of Spintech, a subsidiary of the Company, since November, 1995. From July 1991 until July 1997, he also served as President and Chief Financial Officer of the Company. From 1980 until the consummation of the Company's public offering in November 1995, he had been primarily engaged as the principal owner and Chief Executive of U.S. Asian Consulting Group, Inc., a New Jersey based provider of consulting services in "work-out" and "turnaround" situations for publicly and privately owned companies in financial difficulty.

About
Milestone Scientific Inc
.

Milestone Scientific is the developer, manufacturer and marketer of The WandÒ computer controlled local anesthetic delivery system.  The Wand system comprises a computer controlled drive unit and features The Wand hand piece, a single patient use product that is held in a pen like manner for injections. This proprietary technology forms the basis of their value proposition, which enables practitioners to consistently administer injections with improved control, greater comfort, reduced trauma and less stress for both the patient and practitioner.

The Wand system was introduced to the dental market for a wide variety of procedures, including the Periodontal Ligament Injection (PDL).  The Wand Plus, an enhanced version of The Wand, recently received FDA clearance to market for medical uses. 

Milestone Scientific has recently received a broad US patent on CompuFloÔ, an enabling technology for computer controlled infusion of a wide array of liquid drugs and other fluids, aspiration of bodily fluids and measurement of in-tissue pressure. 

CEOCFOinterviews: Mr. Osser, can you give us a brief history of Milestone Scientific?

Mr. Osser:
Milestone Scientific is an ten-year-old company whose mission was to become a virtual company. It was to acquire breakthrough technology in the medical field, a either disposable or have a disposable component, get broad patents on that technology worldwide, commercialize the technology, outsource engineering and manufacturing. A marketing plan would be developed to support global product introductions and then acquire outside distribution for the product. Our history has been in the take over of a company that had a breakthrough technology. We acquired a technology that is the first enhancement in our sector in 150 years. Revolutionarily changing the hypodermic needle syringe through a computerized system, that’s ergonomically sound, virtually painless to the patient, much less stressful for the practitioner, much enhanced infection control, and does not kill tissue (necrosis)., It is a revolutionary device, which will go into many fields over the coming years and as of August of this year (2001), will be introduced into the medical field.

Milestone Scientific acquired the product in 1995, and introduced it into the dental field in the United States in early 1998.

CEOCFOinterviews: Currently, where are you in the development, redevelopment or redefining of your product?

To receive a complete copy of this interview call: 570-839-0236

 

ceocfointerviews.com does not purchase or make
recommendation on stocks based on the interviews published.

.